Pacific Smiles Group Limited
Pacific Smiles Group Limited (PSQ.AX) Financial Performance & Income Statement Overview
Explore the financials of Pacific Smiles Group Limited (PSQ.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
Pacific Smiles Group Limited (PSQ.AX) Income Statement & Financial Overview
Review Pacific Smiles Group Limited PSQ.AX income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $98.98M | $89.88M | $90.002M | $83.71M |
| Cost of Revenue | $53.08M | $45.83M | $68.58M | $66.31M |
| Gross Profit | $45.90M | $44.05M | $21.42M | $17.41M |
| Gross Profit Ratio | $0.46 | $0.49 | $0.24 | $0.21 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $33.44M | $22.39M | $14.36M | $13.03M |
| Operating Expenses | $33.44M | $22.39M | $14.36M | $13.03M |
| Total Costs & Expenses | $86.52M | $68.23M | $82.94M | $79.34M |
| Interest Income | $0.00 | $470000.00 | $17000.00 | $171000.00 |
| Interest Expense | $0.00 | $2.16M | $2.00M | $2.37M |
| Depreciation & Amortization | $14.34M | -$1.03M | $15.31M | $15.75M |
| EBITDA | $12.57M | $5.71M | $22.90M | $21.76M |
| EBITDA Ratio | $0.13 | $0.06 | $0.25 | $0.24 |
| Operating Income | $12.46M | $21.65M | $7.06M | $4.38M |
| Operating Income Ratio | $0.13 | $0.24 | $0.08 | $0.05 |
| Other Income/Expenses (Net) | -$15.69M | -$16.54M | -$1.45M | -$730000.00 |
| Income Before Tax | -$3.23M | $5.12M | $5.61M | $3.65M |
| Income Before Tax Ratio | -$0.03 | $0.06 | $0.06 | $0.04 |
| Income Tax Expense | -$1.24M | $1.49M | $1.20M | $1.45M |
| Net Income | -$1.99M | $3.63M | $4.41M | $2.20M |
| Net Income Ratio | -$0.02 | $0.04 | $0.05 | $0.03 |
| EPS | -$0.01 | $0.02 | $0.03 | $0.01 |
| Diluted EPS | -$0.01 | $0.02 | $0.03 | $0.01 |
| Weighted Avg Shares Outstanding | $161.63M | $159.58M | $159.58M | $159.58M |
| Weighted Avg Shares Outstanding (Diluted) | $161.62M | $159.58M | $159.58M | $159.58M |
The company's financials show resilient growth, with revenue advancing from $83.71M in Q4 2023 to $98.98M in Q2 2025. Gross profit remained healthy with margins at 46% in Q2 2025 compared to 21% in Q4 2023. Operating income hit $12.46M last quarter, sustaining a consistent 13% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $12.57M. Net income dropped to -$1.99M, while earnings per share reached -$0.01. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan